|
2024
|
Invention
|
Method for preparation of n-acetyl cysteine amide or di- n-acetyl cysteine amide and derivatives.... |
|
|
Invention
|
Methods of making deuterium-enriched n-acetylcysteine amide (d-naca) and (2r,2r)-3,3-disulfanediy... |
|
2023
|
Invention
|
Treatment of age-related macular degeneration, glaucoma, and diabetic retinopathy with n-acetylcy... |
|
|
Invention
|
Ophthalmic implant.
The present invention relates in general to compositions and methods for tre... |
|
|
Invention
|
Ophthalmic implant. The present invention relates in general to compositions and methods for trea... |
|
|
Invention
|
Method for preparation of n-acetyl cysteine amide and derivatives thereof.
Presented herein are ... |
|
2022
|
Invention
|
Treatment of ferroptosis. The present invention relates in general to the field of compositions a... |
|
|
Invention
|
Treatment of ferroptosis.
The present invention relates in general to the field of compositions ... |
|
2021
|
Invention
|
Method for preparation of n-acetyl cysteine amide and derivatives thereof. The present invention ... |
|
|
Invention
|
Treatment of cystinosis. The present invention relates in general to the field of compositions an... |
|
|
Invention
|
Prevention or treatment of covid-19. The present invention includes a method for prevention, trea... |
|
|
Invention
|
Treatment of cystinosis.
The present invention relates in general to the field of compositions a... |
|
|
Invention
|
Prodrug for the treatment of disease and injury of oxidative stress. The present invention includ... |
|
|
Invention
|
Prodrug for the treatment of disease and injury of oxidative stress.
The present invention inclu... |
|
2020
|
Invention
|
Methods of making deuterium-enriched n-acetylcysteine amide (d-naca) and (2r, 2r′)-3,3′-disulfane... |
|
|
G/S
|
Medical and scientific research in the fields of retinal-based and other ocular diseases and opht... |
|
|
Invention
|
N-acetylcysteine amide (naca) and (2r,2r')-3,3' disulfanediyl bis(2-acetamidopropanamide) (dinaca... |
|
|
Invention
|
N-acetylcysteine amide (naca) and (2r,2r')-3-3'-disulfanediyl bis (2-acetamidopropanamide) (dinac... |
|
|
Invention
|
N-acetylcysteine amide (naca) and (2r,2r')-3,3'-disulfanediyl bis (2-acetamidopropanamide) (dinac... |
|
|
Invention
|
Treatment of age-related macular degeneration, glaucoma, and diabetic retinopathy with n-acetylic... |
|
|
Invention
|
Quantitation of free and total n-acetylcysteine amide and its metabolite n-acetylcysteine in huma... |
|
2018
|
Invention
|
Compositions and methods for treatment of eye diseases. The present invention includes compositio... |
|
|
Invention
|
Compositions and methods for treatment of eye diseases.
The present invention includes compositi... |
|
|
Invention
|
Methods of making deuterium-enriched n-acetylcysteine amide (d-naca) and (2r,2r')-3,3' -disulfane... |
|
|
Invention
|
Methods of making deuterium-enriched n-acetylcysteine amide (d-naca) and (2r,2r')-3,3'-disulfaned... |
|
|
Invention
|
Methods of making deuterium-enriched n-acetylcysteine amide (d-naca) and (2r, 2r')-3,3'-disulfane... |
|
2017
|
Invention
|
Method for the preparation of n-acetyl cysteine amide. The present application discloses an effic... |
|
2015
|
Invention
|
Biomarkers useful in the treatment of subjects having diseases of the eye. The present invention ... |
|
|
Invention
|
Treatment of retinitis pigmentosa with n-acetylcysteine amide.
The present invention includes a ... |
|
|
Invention
|
Treatment of retinitis pigmentosa with n-acetylcysteine amide. The present invention includes a m... |
|
|
Invention
|
Method for preparation of n-acetyl cysteine amide. The present application discloses an efficient... |
